Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/222773
Title: Organizing pneumonia in hospitalized COVID-19 patients: risk factors and long-term outcomes
Author: Cuerpo Cardeñosa, Sandra
Hernández González, Fernanda
Benegas, Mariana
Albacar Riobóo, Núria
López Giraldo, Alejandra
Cobo, Inés
Suárez, Samara
Torres, Verónica
Salazar, Adelaido
Soler, Néstor
Noboa Sevilla, María
Frino García, Alejandro
Pérez Rodas, Nancy
Francesqui, Joel
Alsina Restoy, Xavier
Muñoz Fernández, Ana María
Roger, Nuria
Prieto González, Sergio
Vlagea, Alexandru
Ruiz, Estibaliz
Faner, Rosa
Barberà i Mir, Joan Albert
Soriano Viladomiu, Alex
Badia, Joan Ramon
Molina Molina, María
Sibila Vidal, Oriol
Sánchez, Marcelo
Agustí García-Navarro, Àlvar
García Aymerich, Judith
Sellarés Torres, Jacobo
Keywords: COVID-19
Pneumònia
COVID-19
Pneumonia
Issue Date: 4-Jul-2025
Publisher: Springer Science and Business Media LLC
Abstract: Background Some patients develop post-COVID-19 organizing pneumonia (OP) that is responsive to corticosteroid treatment. This multicenter, case-control study of patients hospitalized for COVID-19 sought to determine the prevalence, risk factors, radiological outcomes, and evolution after treatment. Methods We included 153 consecutive patients with OP and 140 without OP who required hospitalization because of COVID-19 from February to April 2020. OP patients were followed up for 12 months, with visits at 1, 3, 6, and 12 months after hospital discharge. Results Risk factors for OP at hospital admission were advanced age, previous respiratory disease, and elevated C-reactive protein levels. Follow-up computed thoracic (CT) scans performed one year after admission showed progressive improvement in radiological involvement; however, up to 57% of patients with OP remained with fibrotic-like changes. Multivariate analysis showed a significant association of fibrotic pattern with older age, high dose of corticosteroids, and extensive parenchymal lung involvement on admission CT scans. Conclusions Following COVID-19 OP, fibrotic-like changes may persist over the long term. Higher dose of corticosteroids does not seem to be associated with a better prognosis.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s41479-025-00169-9
It is part of: Pneumonia, 2025, vol. 17, num. 1
URI: https://hdl.handle.net/2445/222773
Related resource: https://doi.org/10.1186/s41479-025-00169-9
ISSN: 2200-6133
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
s41479-025-00169-9.pdf1.62 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons